Based on an international programme backed by WHO on the evaluation of pharmaceuticals, this book will look at models used in different countries and will discuss the issues surrounding this important aspect of health care: the involvement of different stakeholders, the economic and epidermiological aspects, the tensions between licensing and valuation. The authors believe the book would fill a gap between publications on trial analyses, meta analyses and guidelines, and the decision making processes of organisations such as NICE, and at the local level HMOs or health trusts. Chapters will be...